Commonwealth Equity Services’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $67K | Buy |
61,155
+17,905
| +41% | +$19.6K | ﹤0.01% | 4128 |
|
2025
Q1 | $42K | Buy |
43,250
+17,000
| +65% | +$16.5K | ﹤0.01% | 4084 |
|
2024
Q4 | $41K | Buy |
26,250
+10,000
| +62% | +$15.6K | ﹤0.01% | 3998 |
|
2024
Q3 | $60K | Hold |
16,250
| – | – | ﹤0.01% | 3914 |
|
2024
Q2 | $54K | Sell |
16,250
-14,000
| -46% | -$46.5K | ﹤0.01% | 3886 |
|
2024
Q1 | $129K | Buy |
30,250
+17,300
| +134% | +$73.8K | ﹤0.01% | 3755 |
|
2023
Q4 | $23K | Hold |
12,950
| – | – | ﹤0.01% | 3810 |
|
2023
Q3 | $26K | Buy |
+12,950
| New | +$26K | ﹤0.01% | 3715 |
|